Delivery Order SPE2DB20D3103-SPE2DB25FN0V6
Award Date
3/14/25
Potential Completion Date
3/17/25
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of medical products such as the prescription medication Jolessa. The contract, valued at $1,039.11, is a delivery order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This $999,999,999.00 IDC serves as the primary vehicle for...
This federal contract award, with ID SPE2DB20D7066|SPE2DB25FC2DP, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,203.28 firm-fixed-price delivery order is for the supply of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The contract has an ultimate completion date of January 28, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,034.16, is for the delivery of JOLESSA 0.15 MG-0.03 MG tablets, a prescription medication. This award is not set aside for a specific business type. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Jolessa 0.15 mg-0.03 mg tablets, a pharmaceutical product, with a ceiling value of $1,178.45 and a performance period ending on June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a $5,871.06 firm-fixed price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The contract is to provide the drug product JOLESSA 0.15 MG-0.03 MG TABLET 91S to DLA facilities. Amerisourcebergen also holds a $999,999,999.00 Indefinite Delivery Contract with DLA Troop Support Medical to deliver a comprehensive range of pharmaceutical products and medical supplies to support the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The award, valued at $1,130.22, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. The delivery order is a firm fixed price contract with a completion date of February 26, 2024. Amerisourcebergen Drug Corp, through its...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,334.60, is for the delivery of the prescription medication Jolessa 0.15 mg-0.03 mg tablet. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 1, 2023. The contract is not designated as a set-aside award. AmerisourceBergen holds a...
This federal contract award, with the ID SPE2DB20D3103|SPE2DB22FN9H2, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The $2,213.48 firm fixed-price delivery order is for the pharmaceutical product JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor providing a...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,293.03, is for the delivery of the prescription medication Jolessa 0.15 mg-0.03 mg tablet. The contract is not a set-aside and is a firm fixed-price delivery order, with a performance period through May 2, 2025. AmerisourceBergen Drug Corp, based in Conshohocken, Pennsylvania, is...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $9,288.90 award is for the supply of pharmaceutical products, specifically "JOLESSA TABS 3X 91S", to support military treatment programs and facilities. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA with a potential value of...